Aggarwal Gaurav has filed 19 insider transactions across 2 companies since March 2023.
Most recent transaction: a transaction of 652900 shares of Unicycive Therapeutics, Inc. ($UNCY) on August 25, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 25, 2025 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Common Stock | 652900 | $0.00 | 1,789,915.0000 | 12,302,059 | 57.42% | 5.31% |
| Aug. 25, 2025 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | D | Series A-2 Prime Preferred Stock | 3199 | $1000.00 | 0.0000 | 12,302,059 | 100.00% | 0.03% |
| July 28, 2025 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | A | Stock Options | 21200 | $0.00 | 39,200.0000 | 12,302,059 | 117.78% | 0.17% |
| May 21, 2025 | GERON CORP | $GERN | Aggarwal Gaurav | Director | A | Stock Option (right to buy) | 180000 | $0.00 | 180,000.0000 | 646,033,247 | 9999.99% | 0.03% |
| Feb. 18, 2025 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Common Stock | 1400000 | $0.00 | 11,370,152.0000 | 66,985,129 | 14.04% | 2.09% |
| Feb. 18, 2025 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | D | Series A-2 Prime Preferred Stock | 686 | $1000.00 | 3,119.2100 | 66,985,129 | 18.03% | 0.00% |
| Oct. 9, 2024 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | D | Series A-2 Prime Preferred Stock | 2695 | $1000.00 | 3,885.2100 | 8,894,321 | 40.96% | 0.03% |
| Oct. 9, 2024 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Common Stock | 5500000 | $0.00 | 9,970,152.0000 | 8,894,321 | 123.04% | 61.84% |
| May 9, 2024 | GERON CORP | $GERN | Aggarwal Gaurav | Not found | A | Stock Option (right to buy) | 180000 | $0.00 | 180,000.0000 | 570,645,405 | 9999.99% | 0.03% |
| Dec. 29, 2023 | GERON CORP | $GERN | Aggarwal Gaurav | Director | A | Common Stock | 1970 | $0.00 | 1,970.0000 | 380,784,846 | 9999.99% | 0.00% |
| Nov. 26, 2023 | GERON CORP | $GERN | Aggarwal Gaurav | Director | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 380,784,846 | 9999.99% | 0.05% |
| Sept. 5, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | A | Stock Options | 180000 | $0.00 | 180,000.0000 | 15,234,570 | 9999.99% | 1.18% |
| July 11, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Common Stock | 3470152 | $0.00 | 3,470,152.0000 | 15,234,570 | 9999.99% | 22.78% |
| July 11, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Series A-1 Preferred Stock | 8077 | $1000.00 | 0.0000 | 15,234,570 | 100.00% | 0.05% |
| July 11, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Series A-2 Preferred Stock | 13429000 | $0.00 | 13,429,000.0000 | 15,234,570 | 9999.99% | 88.15% |
| July 11, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Tranche A Warrants (right to buy) | 12802388 | $0.00 | 12,802,388.0000 | 15,234,570 | 9999.99% | 84.04% |
| July 11, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Tranche B Warrants (right to buy) | 11638534 | $0.00 | 11,638,534.0000 | 15,234,570 | 9999.99% | 76.40% |
| July 11, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | C | Tranche C Warrants (right to buy) | 18621655 | $0.00 | 18,621,655.0000 | 15,234,570 | 9999.99% | 100.00% |
| March 8, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Aggarwal Gaurav | Director | A | Series A-1 Convertible Preferred Stock | 8077 | $1000.00 | 8,077.0000 | 15,057,049 | 9999.99% | 0.05% |